4

FORM 4 SUBMISSION

Company: RIGEL PHARMACEUTICALS INC
Filed: April 23, 2004
Period of Report: April 23, 2004
Accession Number: 0001209191-04-021816

View Document ↗ View on SEC.gov ↗